Toshihide Higashino and Keito Morimoto et al. revealed that the dysfunctional variant of SLC22A13 reduced the risk of gout and serum uric acid levels, indicating that SLC22A13 is involved in the physiological reabsorption of uric acid salt in the human kidney45. The gene discussed is SLC22A13; the disease is gout.